Pharmaceutical and hygiene compounds
Present in very small quantities in water, the emergent pollutants are nevertheless likely to affect human health. In this context, to conceive the suitable treatments and to anticipate the regulation, the CIRSEE currently carries out three research programs on the pharmaceutical compounds, the pesticides and the endocrine disruptors.
Within the framework of the European program Poséidon (2001-2004), the CIRSEE made studies on antibiotics, the iodized agents of contrast used for the radios, antiepileptic compounds etc. The project gathered 40 people of 7 European countries, and carried on the evaluation of technologies of treatment for the pharmaceutical and hygiene compounds in drinking waters and wastewater. The study made it possible to carry out a state of the art and to enrich considerably our knowledge on those compounds presence and the effectiveness of the treatments, at the same time in drinking water and wastewater treatment plants.
The results concern the occurence and treatability of these compounds ; results are now used on the installations of SUEZ ENVIRONNEMENT to control risks associated to these emergent pollutants. They are also shared by the European Union to accompany the regulation evolution. Within the framework of the revision of the European directive for drinking water, the CIRSEE was requested as an expert on the problems of the endocrine disruptors.
Pharmaceuticals and Personal-Care Products in the water cycle. An international review. Mons Margree
Authors : Pujiker LM., Beausse J., Bruchet A., Glassmeyer S, Fawell JK., Janex Habibi ML., Khiari D., Luck F., Montgomery J., Sacher F.
Source : Global Water Research Coalition (GWRC) ;Keuringsinstitut voor Waterleidingsartikelen (KIWA), 2004, 35 pages.
Pharmaceuticals and personal care products in the water cycle. Report of the GWRC Research Strategy Workgroup.
Authors : Palsma B ; Van Den Hoven T ; Mons M ; Puijker LM ; Beausse J ; Bruchet A ; Glassmeyer S ; Fawell JK ; Janex Habibi ML ; Khiari D ; Luck F. ; Montgomery J ; Sacher F ; Wheale G ; Schulting F.
Source : Global Water Research Coalition (GWRC), 2004, 72 pages.
Effets des traitements d’eau potable et d’épuration des eaux usées sur les résidus médicamenteux. Résultats du projet Poseidon
Authors : M.L. Janex-Habibi, A. Bruchet, T. Ternes.
Source : Techniques Sciences Méthodes, n° 11, nov. 2004, 59-66.
Evaluation et Gestion des risques en production d’eau potable. Application au cas des médicaments et perturbateurs endocriniens.
Authors : J.F. Loret, M.L. Janex-Habibi, O. Schlosser
Source : Cahiers de l’Association Européenne pour l’Eau et la Santé, Vol 10, n°1, 35-42.(2005)
Analysis of Drugs and Personal Care Products in French Source and Drinking Waters : The Analytical Challenge and Examples of Application.
Authors : A. Bruchet, C. Hochereau, C. Picard, V. Decottignies, J.M. Rodrigues and M.L. Janex-Habibi
Source : Wat Sci & Tech, 52, 8, 53-61.(2004)
Removal of PPCP during water treatment. In : Human pharmaceuticals, hormones and fragrances. The challenge of micropollutants in urban water management. Eds Thomas Ternes, Adriano Joss.
Authors: Von Gunten U ; Janex Habibi ML ;
Source : Ternes TA . Editeur : International Water Association (IWA) Publishing, 2006, chapter 8.
